Agammaglobulinaemia despite terminal B-cell differentiation in a patient with a novel LRBA mutation

19Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mutations in lipopolysaccharide-responsive vesicle trafficking, beach and anchor-containing protein (LRBA) cause immune deficiency and inflammation. Here, we are reporting a novel homozygous mutation in LRBA allele in 7-year-old Omani boy, born to consanguineous parents. He presented with type 1 diabetes, autoimmune haematological cytopenia, recurrent chest infections and lymphocytic interstitial lung disease. The patient was treated with CTLA4-Ig (abatacept) with good outcome every 2 weeks for a period of 3 months. He developed complete IgG deficiency, but remarkably, histological examination revealed germinal centres and plasma cells in lymphoid and inflamed lung tissue. Further charatecterisation showed these cells to express IgM but not IgG. This ex vivo analysis suggests that LRBA mutation confers a defect in class switching despite plasma cell formation.

Cite

CITATION STYLE

APA

Al Sukaiti, N., Abdelrahman, K., Alshekaili, J., Al Oraimi, S., Al Sinani, A., Al Rahbi, N., … Cook, M. C. (2017). Agammaglobulinaemia despite terminal B-cell differentiation in a patient with a novel LRBA mutation. Clinical and Translational Immunology, 6(5). https://doi.org/10.1038/cti.2017.20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free